• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Timentin (sterile ticarcillin disodium and clavulanate potassium) for intravenous administration

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – December 2010

Summary View

 

ADVERSE REACTIONS

Renal and Urinary Effects
  • Hemorrhagic cystitis